Ensoma
PrivateLast Round
VC Round
Sep 22, 2025
Total Funding Raised
$255M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ensoma is a biotechnology company that develops in vivo genomic medicine to engineer blood and immune cells for disease treatment using innovative vectors for direct gene modification.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ensoma Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Ensoma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 22, 2025 | ||||
| Series B Extension | May 16, 2023 | ||||
| Series B | Jan 5, 2023 | ||||
| Series A | Feb 11, 2021 |
Ensoma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SymBiosis Capital Management | VC Round, Series B Extension, Series A, Series B |
| Mirae Asset | VC Round, Series B |
| Bioluminescence Ventures | Series B, Series B Extension |
| Cormorant Asset Management | VC Round, Series A, Series B |
| F-Prime Capital | Series A, Series B |
| Arix Bioscience | Series B Extension, Series B |
| 5AM Ventures | VC Round, Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 3, 2025
Presenting new preclinical data at the Society for Immunotherapy of Cancer Annual Meeting.
- Sep 22, 2025
$53M raised with participation from Qatar Investment Authority.
Ensoma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ensoma's valuation, stock price, and market status.